Mineralocorticoid receptor modulators

Details for Australian Patent Application No. 2008230115 (hide)

Owner Merck & Co., Inc.

Inventors Brandish, Philip E.; Hershey, James C.; Steen, Justin T.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-A-2008230115

PCT Pub. Number WO2008/118319

Priority 60/919,740 23.03.07 US

Filing date 19 March 2008

Wipo publication date 2 October 2008

International Classifications

A61K 31/5377 (2006.01)

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/118319 Priority application(s): WO2008/118319

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008230116-Reduction of adverse events.after percutaneous intervention by use of a thrombin receptor antagonist

2008230100-Dispensing valve with hydraulic hammer resistance